Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data

Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data

Background Adherence and persistence are critical to optimising therapeutic benefit from disease-modifying therapies (DMTs) in relapsing-remitting multiple sclerosis (RRMS). This prospective, open-label, multicentre, observational study (AubPRO), conducted in 13 hospital-based neurology clinics arou...

Full description

Bibliographic Details
Main Authors: Steve Vucic, Andrew Lee, Neil Shuey, Cameron Shaw, Todd A Hardy, Stefan Blum, Michael Barnett, Richard Macdonell, William Carroll, Roy G Beran, Heidi Beadnall, Richard Worrell, John Parratt, Jana Moody, Mamdouh Sedhom
Format: Article
Language:English
Published: BMJ Publishing Group 2022-08-01
Series:BMJ Neurology Open
Online Access:https://neurologyopen.bmj.com/content/4/2/e000315.full

Internet

https://neurologyopen.bmj.com/content/4/2/e000315.full

Similar Items